Stock MOLN MOLECULAR PARTNERS AG
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Molecular Partners AG Nasdaq

Equities

MOLN

US60853G1067

Real-time Estimate Cboe BZX
Other stock markets
 09:59:16 2024-06-13 EDT 		5-day change 1st Jan Change
6.1 USD +5.17% Intraday chart for Molecular Partners AG +42.52% +45.94%
06-12 Top Premarket Gainers MT
06-11 Molecular Partners Announces the Debut of their Lead Radio-Darpin Therapy Candidate MP0712, Targeting DLL3 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 123B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 111B
BIONTECH SE Stock BioNTech SE
 23.63B -
ARGENX SE Stock argenx SE
 22.58B -
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
 17.61B
  1. Stock Market
  2. Equities
  3. MOLN Stock
  4. MOLN Stock
  5. Charts Molecular Partners AG
  6. Sector Chart